DK1991529T3 - Substituerede arylsulfonamider som antivirale midler - Google Patents

Substituerede arylsulfonamider som antivirale midler

Info

Publication number
DK1991529T3
DK1991529T3 DK07722932.6T DK07722932T DK1991529T3 DK 1991529 T3 DK1991529 T3 DK 1991529T3 DK 07722932 T DK07722932 T DK 07722932T DK 1991529 T3 DK1991529 T3 DK 1991529T3
Authority
DK
Denmark
Prior art keywords
antivirals
substituted arylsulfonamides
arylsulfonamides
substituted
Prior art date
Application number
DK07722932.6T
Other languages
English (en)
Inventor
Niels Svenstrup
Dagmar Karthaus
Andreas Goeller
Dirk Heimbach
Kerstin Henninger
Dieter Lang
Bernd Riedl
Rudolf Schohe-Loop
Joachim Schuhmacher
Tobias Wunberg
Holger Zimmermann
Daniela Paulsen
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38180640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1991529(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Application granted granted Critical
Publication of DK1991529T3 publication Critical patent/DK1991529T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
DK07722932.6T 2006-03-03 2007-02-26 Substituerede arylsulfonamider som antivirale midler DK1991529T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006009928A DE102006009928A1 (de) 2006-03-03 2006-03-03 Substituierte Arylsulfonamide
PCT/EP2007/001620 WO2007101573A1 (de) 2006-03-03 2007-02-26 Substituierte arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
DK1991529T3 true DK1991529T3 (da) 2010-04-12

Family

ID=38180640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07722932.6T DK1991529T3 (da) 2006-03-03 2007-02-26 Substituerede arylsulfonamider som antivirale midler

Country Status (26)

Country Link
US (1) US8318761B2 (da)
EP (1) EP1991529B1 (da)
JP (1) JP5255455B2 (da)
KR (1) KR101447758B1 (da)
CN (1) CN101389607B (da)
AR (1) AR059710A1 (da)
AT (1) ATE451356T1 (da)
AU (1) AU2007222689B2 (da)
BR (1) BRPI0707068A2 (da)
CA (1) CA2642602C (da)
DE (2) DE102006009928A1 (da)
DK (1) DK1991529T3 (da)
ES (1) ES2335316T3 (da)
HK (1) HK1125371A1 (da)
IL (1) IL193449A (da)
JO (1) JO2581B1 (da)
MX (1) MX2008011264A (da)
PE (1) PE20080136A1 (da)
PL (1) PL1991529T3 (da)
PT (1) PT1991529E (da)
RU (1) RU2423352C2 (da)
TW (1) TWI388559B (da)
UA (1) UA95103C2 (da)
UY (1) UY30178A1 (da)
WO (1) WO2007101573A1 (da)
ZA (1) ZA200807189B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP2103318A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103317A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103316A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethandispersionen
EP2103638A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethanlösungen
DE102008025613A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
DE102008025614A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
WO2010025841A1 (de) 2008-09-04 2010-03-11 Bayer Materialscience Ag Tcd-basierte hydrophile polyurethanlösungen
DE102011101446A1 (de) 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
EP2853532B1 (en) * 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
CN109879817B (zh) * 2019-03-19 2020-10-02 扬州大学 甲基二磺隆的制备方法
RU2738848C1 (ru) * 2019-10-24 2020-12-17 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
AU765203B2 (en) 1999-04-19 2003-09-11 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19930075A1 (de) 1999-06-30 2001-01-04 Bayer Ag Neue Amino- und Amidosulfonamide als antivirale Mittel
CN1516695A (zh) * 2001-04-19 2004-07-28 用作抗病毒剂的芳基磺酰胺类化合物
DE10138578A1 (de) * 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide

Also Published As

Publication number Publication date
CA2642602C (en) 2014-05-13
EP1991529A1 (de) 2008-11-19
RU2423352C2 (ru) 2011-07-10
PE20080136A1 (es) 2008-04-18
KR101447758B1 (ko) 2014-10-06
ATE451356T1 (de) 2009-12-15
IL193449A (en) 2013-02-28
BRPI0707068A2 (pt) 2011-04-19
MX2008011264A (es) 2008-09-12
UY30178A1 (es) 2007-09-28
AU2007222689B2 (en) 2011-11-17
JP2009529016A (ja) 2009-08-13
KR20080107456A (ko) 2008-12-10
UA95103C2 (ru) 2011-07-11
HK1125371A1 (en) 2009-08-07
IL193449A0 (en) 2009-05-04
ZA200807189B (en) 2009-12-30
PT1991529E (pt) 2010-01-06
CA2642602A1 (en) 2007-09-13
PL1991529T3 (pl) 2010-05-31
US8318761B2 (en) 2012-11-27
RU2008139195A (ru) 2010-04-10
CN101389607A (zh) 2009-03-18
DE102006009928A1 (de) 2007-09-06
TW200813034A (en) 2008-03-16
ES2335316T3 (es) 2010-03-24
EP1991529B1 (de) 2009-12-09
US20090176842A1 (en) 2009-07-09
DE502007002264D1 (de) 2010-01-21
AU2007222689A1 (en) 2007-09-13
TWI388559B (zh) 2013-03-11
AR059710A1 (es) 2008-04-23
JO2581B1 (en) 2011-02-27
JP5255455B2 (ja) 2013-08-07
WO2007101573A1 (de) 2007-09-13
CN101389607B (zh) 2011-09-07

Similar Documents

Publication Publication Date Title
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
DK1991529T3 (da) Substituerede arylsulfonamider som antivirale midler
DK2364293T3 (da) Hidtil ukendte pyrazol-4-N-alkoxycarboxamider som mikrobiocider
DK1863818T3 (da) Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
DK2086939T3 (da) Pyridiacarboxamid som II-beta-HSDI-inhibitorer
DK1856042T3 (da) Substituerede gamma-lactamer som terapeutiske midler
DK1960352T3 (da) 2-adamantylurinstof-derivater som selektive 11beta-hsd1 inhibitorer
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
DK2369934T3 (da) Spiroheterocykliske n-oxypiperidiner som pesticider
DK2102205T3 (da) Pyridopyrazinderivater anvendelige som herbicidale forbindelser
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
DK2125748T3 (da) Acylaminopyrazol som FGFR inhibitorer
DK2291368T3 (da) Substitueret gamma-lactam som terapeutisk middel
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
DK1912647T3 (da) Quinolinderivater som antibakterielle midler
BRPI0714764A2 (pt) Derivados substituídos de sulfonamida
FI20065388A0 (fi) Betuliiniperäiset yhdisteet antimikrobisina aineina
CR10353A (es) Nuevos compuestos.
DK1912648T3 (da) Quinolinderivater som antibakterielle midler
DK2078001T3 (da) Diazepan-acetamidderivater som selektive 11-HSD1-inhibitorer
DK2383271T3 (da) Aminoquinoloner som GSK-3-inhibitorer
FI20060217A0 (fi) Sprinkleri
DK1937671T3 (da) Benzimidazolthiophenforbindelser som PLK-inhibitorer
DK2069310T3 (da) Sulfonylpyrazolin-1-carboxamidin-derivater som 5-HT6-antagonister